pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
371
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
lonvoguran
lonvoguran
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
$NTLA
Intellia Therapeutics, Inc.
Marketed
mavorixafor
Xolremdi (mavorixafor)
Neutropenia
$XFOR
X4 Pharmaceuticals, Inc
Phase 2
mavrilimumab
mavrilimumab
Rheumatoid Arthritis
MedImmune Ltd
← prev
page 11 of 13
next →
Pain
89
Neurology
1
Marketed
meloxicam
Qamzova (meloxicam)
Post-Operative Pain
Nanjing Delova Biotech Co Ltd
Marketed
mepolizumab
Nucala (mepolizumab)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra…
GlaxoSmithKline LLC
Marketed
methoxsalen
Methoxsalen
Vitiligo
Allergan Finance LLC
Phase 3
mivocabtagene autoleucel
mivocabtagene autoleucel [INN]
Myasthenia Gravis
$KYTX
Kyverna Therapeutics, Inc.
Marketed
mycophenolate mofetil hydrochloride
Mycophenolate Mofetil Hydrochloride
Heart Transplant Rejection
Meitheal Pharmaceuticals Inc
Marketed
mycophenolic acid DR
Mycophenolic Acid
Kidney Transplant Rejection
TWi Pharmaceuticals USA Inc
Phase 3
navenibart
navenibart
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
$BCRX
BIOCRYST PHARMACEUTICALS INC
Phase 2
nemolizumab
Nemluvio (nemolizumab)
Systemic Sclerosis (Scleroderma)
Galderma SA
pre_registration
nipocalimab
Imaavy (nipocalimab-aahu)
Acquired (Autoimmune) Hemolytic Anemia
$JNJ
JOHNSON & JOHNSON
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AUTL
Autolus Therapeutics plc
Phase 3
obexelimab
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
$ZBIO
Zenas BioPharma, Inc.
Marketed
omalizumab
Xolair (omalizumab)
Chronic Urticaria
Genentech Inc
Phase 3
onvuzosiran sodium
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
ADARx Pharmaceuticals Inc
Phase 2
orismilast
orismilast [INN]
Plaque Psoriasis (Psoriasis Vulgaris)
Union Therapeutics AS
Marketed
oxaprozin
Coxanto (oxaprozin)
Juvenile Rheumatoid Arthritis
Solubiomix LLC
Phase 2
ozureprubart
ozureprubart
Food Allergy
RAPT Therapeutics Inc
Marketed
peanut (Arachis hypogaea) allergen
Palforzia
Peanut Allergy
Aimmune Therapeutics Inc
Phase 2
pegtarazimod hydrochloride
pegtarazimod hydrochloride
Chronic Obstructive Pulmonary Disease (COPD)
ReAlta Life Sciences Inc
Phase 3
piclidenoson
piclidenoson
Plaque Psoriasis (Psoriasis Vulgaris)
$CANF
Can-Fite BioPharma Ltd.
Marketed
ponesimod
Ponvory (ponesimod)
Ulcerative Colitis
$VNDA
Vanda Pharmaceuticals Inc.
Phase 3
pozelimab
Veopoz (pozelimab-bbfg)
Myasthenia Gravis
$REGN
REGENERON PHARMACEUTICALS, INC.
Marketed
prednicarbate
Prednicarbate Oceanside (prednicarbate)
Psoriasis
Oceanside Pharmaceuticals Inc
Marketed
prednisolone
Prednisolone (prednisolone [INN])
Allergic Conjunctivitis
Teva Pharmaceuticals USA Inc
Marketed
prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Mission Pharmacal Co
Marketed
prednisone
Prednisone (prednisone [INN])
Aspiration Pneumonitis
Vintage Pharmaceuticals Inc (Inactive)
Marketed
promethazine
Promethazine Hydrochloride (promethazine [INN])
Allergic Conjunctivitis
Nostrum Laboratories LLC
Phase 1
prulacabtagene leucel
prulacabtagene leucel
B-Cell Non-Hodgkin Lymphoma
$ACET
Adicet Bio, Inc.
